Dorsey & Whitney Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.04M Sell
29,591
-955
-3% -$65.9K 0.11% 164
2025
Q1
$2.12M Sell
30,546
-948
-3% -$65.8K 0.12% 152
2024
Q4
$2.71M Buy
31,494
+136
+0.4% +$11.7K 0.15% 129
2024
Q3
$3.73M Buy
31,358
+1,382
+5% +$165K 0.2% 110
2024
Q2
$4.28M Sell
29,976
-1,739
-5% -$248K 0.3% 87
2024
Q1
$4.07M Buy
31,715
+339
+1% +$43.5K 0.28% 87
2023
Q4
$3.25M Buy
31,376
+1,142
+4% +$118K 0.25% 101
2023
Q3
$2.75M Sell
30,234
-80
-0.3% -$7.28K 0.24% 103
2023
Q2
$2.45M Buy
30,314
+1,516
+5% +$123K 0.2% 115
2023
Q1
$2.29M Buy
28,798
+294
+1% +$23.4K 0.21% 109
2022
Q4
$1.93M Buy
28,504
+2,902
+11% +$196K 0.19% 121
2022
Q3
$1.28M Buy
25,602
+514
+2% +$25.6K 0.13% 150
2022
Q2
$1.4M Buy
25,088
+638
+3% +$35.6K 0.14% 143
2022
Q1
$1.36M Buy
24,450
+1,550
+7% +$86.1K 0.12% 161
2021
Q4
$1.28M Buy
22,900
+698
+3% +$39.1K 0.11% 170
2021
Q3
$1.07M Sell
22,202
-22
-0.1% -$1.06K 0.1% 184
2021
Q2
$930K Buy
22,224
+94
+0.4% +$3.93K 0.09% 195
2021
Q1
$746K Buy
22,130
+1,318
+6% +$44.4K 0.07% 219
2020
Q4
$727K Buy
20,812
+54
+0.3% +$1.89K 0.08% 203
2020
Q3
$720K Buy
20,758
+18
+0.1% +$624 0.1% 184
2020
Q2
$680K Buy
20,740
+40
+0.2% +$1.31K 0.1% 185
2020
Q1
$624K Sell
20,700
-310
-1% -$9.35K 0.11% 166
2019
Q4
$606K Sell
21,010
-4
-0% -$115 0.08% 196
2019
Q3
$543K Sell
21,014
-386
-2% -$9.97K 0.08% 207
2019
Q2
$546K Buy
21,400
+94
+0.4% +$2.4K 0.08% 198
2019
Q1
$557K Buy
21,306
+7,852
+58% +$205K 0.09% 185
2018
Q4
$310K Buy
13,454
+840
+7% +$19.4K 0.05% 248
2018
Q3
$297K Buy
12,614
+1,494
+13% +$35.2K 0.05% 285
2018
Q2
$257K Sell
11,120
-90
-0.8% -$2.08K 0.04% 295
2018
Q1
$276K Sell
11,210
-334
-3% -$8.22K 0.05% 259
2017
Q4
$310K Buy
+11,544
New +$310K 0.06% 230
2016
Q3
Sell
-9,244
Closed -$248K 312
2016
Q2
$248K Buy
+9,244
New +$248K 0.06% 221